In this study, we developed in situ hybridisation probes to evaluate the presence of FRAT1 and used an anti-β-catenin antibody to evaluate by immunohistochemistry the expression levels and subcellular localisation of β-catenin in formalin-fixed, paraffin-embedded human normal tissues and ovarian tumour tissues. This evidence concerns the gene FRAT1 and ovarian neoplasm.